Interpret this CBC with differential: WBC 17.3 ×10⁹/L (neutrophils 73.5%, absolute neutrophils 12.8 ×10⁹/L), immature granulocytes 1.8% (0.3 ×10⁹/L), lymphocytes 8.5% (1.5 ×10⁹/L), monocytes 9.2% (1.6 ×10⁹/L), eosinophils 6.1% (1.1 ×10⁹/L), basophils 0.9% (0.2 ×10⁹/L), nucleated red blood cells 1.7% (0.3 ×10⁹/L); RBC 2.90 ×10¹²/L, hemoglobin 8.1 g/dL, hematocrit 26.3%, MCV 90.7 fL, MCH 27.9 pg, MCHC 30.8 g/dL, RDW 18.6%, platelets 233 ×10⁹/L, MPV 9.4 fL.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CBC Interpretation: Concerning for Hematologic Malignancy Requiring Urgent Evaluation

This CBC demonstrates leukocytosis with left shift, immature granulocytes, nucleated RBCs, normocytic anemia with elevated RDW, and relative lymphopenia—a constellation highly suspicious for a myeloproliferative neoplasm, most likely chronic myeloid leukemia (CML), requiring immediate peripheral smear review, BCR-ABL1 testing, and hematology consultation. 1, 2

Critical Abnormalities Identified

White Blood Cell Abnormalities

  • WBC 17.3 × 10⁹/L with neutrophilia (73.5%, absolute 12.8 × 10⁹/L): This moderate leukocytosis with neutrophil predominance falls below the typical CML threshold of >25 × 10⁹/L but exceeds normal limits and warrants investigation 2, 3
  • Immature granulocytes 1.8% (0.3 × 10⁹/L absolute): The presence of immature granulocytes in peripheral blood is abnormal and indicates either severe physiologic stress or an underlying myeloproliferative neoplasm 2
  • Nucleated RBCs 1.7% (0.3 × 10⁹/L absolute): This is a critical finding suggesting bone marrow stress, extramedullary hematopoiesis, or marrow infiltration 2
  • Relative lymphopenia (8.5%, absolute 1.5 × 10⁹/L): The disproportionately low lymphocyte percentage in the setting of leukocytosis suggests a myeloid-predominant process 4

Red Blood Cell Abnormalities

  • Severe normocytic anemia: Hemoglobin 8.1 g/dL, hematocrit 26.3%, RBC 2.90 × 10¹²/L with normal MCV (90.7 fL) indicates anemia of chronic disease or bone marrow failure 5
  • Elevated RDW 18.6%: This suggests heterogeneous red cell populations, consistent with ongoing marrow stress or dysplasia 4

Other Findings

  • Monocytosis: Absolute monocyte count 1.6 × 10⁹/L (≥1.0 × 10⁹/L threshold) requires evaluation for chronic myelomonocytic leukemia (CMML) or other myeloid neoplasms 6
  • Eosinophilia: Absolute eosinophil count 1.1 × 10⁹/L is elevated and may accompany CML 2
  • Basophilia: Absolute basophil count 0.2 × 10⁹/L—while only mildly elevated, basophilia ≥200/mm³ strongly suggests CML rather than reactive causes 2

Differential Diagnosis

Primary Concern: Chronic Myeloid Leukemia

CML is the leading diagnosis based on the following features 1, 2:

  • Left shift with immature granulocytes representing the full spectrum of myeloid maturation 2
  • Basophilia and eosinophilia accompanying the leukocytosis 2
  • Nucleated RBCs indicating marrow stress 2
  • Normocytic anemia consistent with CML presentation 5

Key distinguishing features from the typical CML presentation 1:

  • WBC is only 17.3 × 10⁹/L rather than the characteristic >100 × 10⁹/L seen in most CML cases
  • However, CML can present with lower WBC counts, and the qualitative findings (immature granulocytes, basophilia, eosinophilia, nucleated RBCs) are more diagnostically significant than the absolute WBC count 5, 2

Alternative Considerations

Chronic Myelomonocytic Leukemia (CMML): The monocytosis (1.6 × 10⁹/L) raises concern for CMML, which requires persistent monocytosis with dysplasia and <20% blasts 6

Reactive Leukocytosis: Less likely given the combination of immature granulocytes, nucleated RBCs, and multiple cell line abnormalities 3, 7

  • Infections typically cause leukocytosis with toxic granulations but not nucleated RBCs 3
  • Adult-onset Still's disease can cause WBC >15 × 10⁹/L with neutrophilia but would not explain the immature granulocytes and nucleated RBCs 5, 6

Acute Myeloid Leukemia (AML): Less likely because AML typically presents with circulating blasts, more severe cytopenias, and lacks the orderly myeloid maturation seen here 1

Immediate Diagnostic Workup Required

Urgent Laboratory Studies

  1. Manual peripheral blood smear review to confirm automated differential, assess myelocyte proportion, evaluate for dysplasia, and identify any blasts 2, 4
  2. BCR-ABL1 testing by RT-PCR: This is diagnostic for CML and must be performed immediately 5, 2
  3. Repeat CBC with manual differential to document percentages of all immature forms (blasts, promyelocytes, myelocytes, metamyelocytes) 2

Bone Marrow Evaluation

Bone marrow aspiration and biopsy are mandatory given the constellation of findings 2, 6:

  • Assess marrow cellularity and blast percentage 6
  • Conventional cytogenetic analysis to detect Philadelphia chromosome t(9;22) 5, 2
  • FISH for BCR-ABL1 if cytogenetics cannot be analyzed 5
  • Gomori silver staining to assess for reticulin fibrosis (present in 30% of CML cases) 5

Additional Testing

  • Molecular testing: If BCR-ABL1 is negative, test for PDGFRA/PDGFRB rearrangements (given eosinophilia) and mutations in TET2, SRSF2, ASXL1, and RAS genes to evaluate for CMML 6

Clinical Context Assessment

History to Obtain

  • Constitutional symptoms: Weight loss, night sweats, fever, fatigue (present in 40-50% of CML cases) 1
  • Splenomegaly symptoms: Early satiety, left upper quadrant fullness (splenomegaly in 40-50% of CML) 1
  • Bleeding or bruising: Suggests thrombocytopenia or coagulopathy 5
  • Infection symptoms: To exclude reactive causes 3
  • Medication history: Corticosteroids, lithium, beta-agonists can cause reactive leukocytosis 7

Physical Examination

  • Splenomegaly: Most consistent finding in CML, present in 40-50% at diagnosis 1
  • Hepatomegaly: Less common but characteristic 1
  • Lymphadenopathy: Evaluate for lymphoproliferative disorders 6

Red Flags for Disease Progression

The following findings would indicate accelerated or blast phase CML 5:

  • Blasts 15-29%: Accelerated phase by European LeukemiaNet criteria 2
  • Blasts ≥30%: Blast phase 2
  • Basophils >20%: Suggests progression 5, 2
  • Platelets <100 × 10⁹/L unrelated to therapy: Accelerated phase criterion 5

Urgent Hematology Consultation Indicated

Immediate hematology referral is mandatory based on 2, 4:

  • Immature granulocytes with WBC >15 × 10⁹/L
  • Nucleated RBCs in peripheral blood
  • Concurrent basophilia and eosinophilia
  • Unexplained normocytic anemia with elevated RDW
  • Monocytosis requiring evaluation for CMML

Common Pitfalls to Avoid

  1. Do not attribute this to infection alone: While infections cause leukocytosis, the presence of nucleated RBCs, immature granulocytes, and basophilia suggests a primary marrow disorder 3, 4
  2. Do not delay BCR-ABL1 testing: This is the definitive diagnostic test for CML and should be ordered immediately 5, 2
  3. Do not rely solely on WBC count: The qualitative findings (cell types present) are more important than the absolute WBC count for diagnosing myeloproliferative neoplasms 2, 4
  4. Do not miss CMML: The monocytosis requires specific evaluation with bone marrow examination if it persists 6

References

Guideline

Differentiating AML from CML on CBC

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Myelocytes in CBC: Clinical Significance and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of Patients with Leukocytosis.

American family physician, 2015

Research

Malignant or benign leukocytosis.

Hematology. American Society of Hematology. Education Program, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Monocytosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Leukocytosis: basics of clinical assessment.

American family physician, 2000

Related Questions

How to manage a patient with leukocytosis, neutrophilia, lymphocytosis, eosinophilia, and basophilia?
What is the appropriate management for a patient with leukocytosis and macrocytic anemia?
What is the best course of action for an 11-year-old male with leukocytosis (elevated WBC count of 10.7), lymphocytes at 4.5, and eosinophils at 0.5?
What is the appropriate follow-up for a 51-year-old male with leukocytosis (elevated White Blood Cell (WBC) count), neutrophilia (elevated neutrophil level), mild hyponatremia (low sodium level), and mild hypochloremia (low chloride level), without a known source of infection?
How should I evaluate an asymptomatic patient with an isolated elevation of the white blood cell count?
What is the recommended community‑acquired pneumonia (CAP) treatment protocol based on severity assessment using CURB‑65 (confusion, urea, respiratory rate, blood pressure, age ≥ 65) or Pneumonia Severity Index (PSI), including outpatient low‑risk, outpatient with comorbidities, inpatient non‑ICU, and ICU regimens?
For a patient with asymptomatic bacteriuria due to ESBL‑producing Enterobacter cloacae that is trimethoprim‑sulfamethoxazole‑susceptible, no sulfa allergy, normal renal function, and no G6PD deficiency, should TMP‑SMX be used as peri‑operative prophylaxis before laser lithotripsy?
When should the first follow‑up appointment be scheduled after initiating antihypertensive medication?
When should iron supplementation be started in a child with avoidant/restrictive food intake disorder (ARFID) who has iron deficiency but a normal hemoglobin level?
After stopping oral iron supplementation for iron deficiency, how long do serum iron, ferritin, and hemoglobin levels take to begin decreasing?
What is the recommended evaluation and management for an adult woman presenting with new‑onset facial or truncal hirsutism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.